当前位置: 首页 > 期刊 > 《河北医学》 > 2005年第9期
编号:10781641
辛伐他汀治疗急性冠脉综合征的疗效观察
http://www.100md.com 《河北医学杂志》 2005年第9期
辛伐,,急性冠脉综合征;辛伐他汀;缺血事件,1资料与方法,2结果,3讨论,参考文献:
     摘要:目的:研究急性冠脉综合征(ACS)早期应用辛伐他汀对血脂、缺血事件发生的影响。方法:60例ACS患者被随机分为对照组(n=30)和治疗组(n=30,用辛伐他汀治疗)观察用药前后血脂、缺血事件发生情况。结果:对照组治疗前后血脂无显著变化(P>0.05)。与对照组相比,治疗组用药后血脂明显下降(P<0.05),缺血事件发生率明显下降(X2=4.72,P<0.05)。两组治疗前、后肝、肾功能,肌酸磷酸激酶水平均无明显变化。结论:ACS早期应用辛伐他汀可明显降低缺血事件发生率。

    关键词:急性冠脉综合征;辛伐他汀;缺血事件

    Evaluation of Simvastatin in the Treatment of Acute Coronary Syndrome

    XIE Xiao-ming, et al

    (Affiliated Hospital of Guangdong Medical College, Guangdong Zhanjiang 524001,China)

    Abstract:Objective: To observe the influence of early simvastatin treatment on serum lipids and ischemic events in patients with acute coronary syndrome(ACS).Method: Sixty patients with ACS were divided into control group(n=30) and therapy group(n=30) randomizely, and the changes of serum lipeid and the incidence of ischemic events were observed.Result: After treatment of simvastatin, the levels of serum lipids and incidence of ischemic events significantly decreased compared with those of control groups (all p<0.05). Before and after treatment, the levels of serum lipids in control group, renal function, Liver function and creatine phosphokinase in both two groups had no change. Conclusion: Early simvastatin treatment could significantly reduce incidence of ischemic events in patients of ACS. ......

您现在查看是摘要页,全文长 5010 字符